ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Impact Of Early Statin Use Following Lung Transplantation On The Development Of Bronchiolitis Obliterans Syndrome

B. Lindner1, S. Strout1, P. Shah2

1Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, 2Department of Pulmonology, The Johns Hopkins Hospital, Baltimore, MD

Meeting: 2019 American Transplant Congress

Abstract number: C328

Keywords: Graft function, Lung, Obilterative bronchiolitis

Session Information

Session Name: Poster Session C: Lung: All Topics

Session Type: Poster Session

Date: Monday, June 3, 2019

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

*Purpose: Conflicting data exists on the effect of statin therapy on the development of bronchiolitis obliterans syndrome (BOS) following lung transplantation, and limited literature is available addressing the impact of early statin initiation in this setting. Prior studies have assessed patients started on statins by 3 months or at variable times post-transplant. This study evaluates whether early statin therapy within the first 30 days following lung transplantation reduces the incidence of BOS at 5 years.

*Methods: Single center, retrospective study of lung transplant recipients from September 2009 – September 2013. The statin group consisted of patients who received early statin therapy (< 30 days after transplant) and remained on therapy for at least 6 months. Patients were excluded if they died or required retransplantation within 6 months post-transplant. BOS was defined using the ISHLT criteria as a reduction in FEV1 to ≤ 80% of post-transplant baseline. Outcomes were assessed for 5 years from transplant and were evaluated using the chi-squared test and multivariate logistic regression.

*Results: Seventy-nine patients were included. Patients in the statin group (n=55) were older, had a lower lung allocation score (LAS), and were more likely to have idiopathic pulmonary fibrosis, whereas the non-statin group (n=24) was more likely to have cystic fibrosis (Table 1). Statins were prescribed for 70% of patients with pravastatin being the most common (94.6% of statin patients). The incidence of BOS at 5 years for statin and non-statin groups was 34.5% and 33.3% (p=0.917). Five year post-transplant survival in the statin and non-statin group was 65.5% and 62.5% (p=0.801). Time to development of BOS and survival free from BOS, retransplantation, or death at 5 years were also not statistically different between the two groups (Table 2). After adjusting for age, native lung disease, and LAS, early statin therapy did not significantly impact the odds of developing BOS (OR 1.44, CI 0.4-5.0, p=0.589).

*Conclusions: Early statin therapy following lung transplantation was not associated with a decreased incidence of BOS, mortality, or event free survival.

 border=

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Lindner B, Strout S, Shah P. The Impact Of Early Statin Use Following Lung Transplantation On The Development Of Bronchiolitis Obliterans Syndrome [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/the-impact-of-early-statin-use-following-lung-transplantation-on-the-development-of-bronchiolitis-obliterans-syndrome/. Accessed June 1, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences